Results 71 to 80 of about 9,596 (222)

Recurrent congenital chylothorax

, 1991
Congenital chylothorax is an uncommon but well-described condition. Recurrent congenital chylothorax is extremely rare. Yancy and Spock (1967) reviewed 31 reported cases of spontaneous chylothorax which occurred in the first 2 months of life and noted ...
Lam, SK, Ghosh, A, Tang, MHY, King, PA
core   +1 more source

Chylothorax after hepatectomy: a case report

Journal of Medical Case Reports, 2018
Background Chylothorax is the accumulation of chyle within the pleural space. Chylothorax can occur as a complication after multiple different types of surgery, most frequently after thoracic surgery, albeit with an incidence rate of less than 1 ...
Ryusei Yamamoto, Yasuji Mokuno, Hideo Matsubara, Hirokazu Kaneko, Yozo Sato, Shinsuke Iyomasa   +5 more
doaj   +1 more source

Thoracic Empyema Secondary to Congenital Chylothorax in a 14-Month-Old Boy with Noonan Syndrome

Case Reports in Pediatrics, 2021
Thoracic empyema usually occurs as a complication of bacterial pneumonia, but in rare cases, it is caused by hematogenous dissemination secondary to nonpulmonary diseases.
Takeru Oikawa, Chiharu Ota, Shinya Iwasawa, Takehiko Onoki, Hideyuki Ikeda, Takushi Hanita   +5 more
doaj   +1 more source

Chylothorax and pseudochylothorax [PDF]

European Respiratory Journal, 1997
Chylothorax is the occurrence of chylus (lymph) in the pleura due to damage to the thoracic duct. There is a high content of triglycerides, and chylomicrons can be seen. It is usually right-sided, since most of the duct is within the right hemithorax. With damage at the level of the aorta, the chyle will appear on the left.
openaire   +2 more sources

Japanese Clinical Practice Guidelines for Vascular Tumors, Vascular Malformations, Lymphatic Malformations, and Lymphangiomatosis 2022

The Journal of Dermatology, Volume 53, Issue 5, Page e257-e356, May 2026.
ABSTRACT The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety, and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Yoshiaki Kinoshita, Kosuke Ishikawa, Sadanori Akita, Katsuyoshi Koh, Satoru Sasaki, Masatoshi Jinnin, Hidefumi Mimura, Keigo Osuga, Michio Ozeki, Michiko Nagahama, Akihiro Fujino, Yoko Aoki, Akiko Asai, Noriko Aramaki‐Hattori, Ryohei Ishiura, Masanori Inoue, Yuki Iwashina, Takafumi Ohshiro, Keiko Ogawa, Mine Ozaki, Junko Ochi, Shiro Onozawa, Motoi Kato, Takahide Kaneko, Tamihiro Kawakami, Akira Kitagawa, Masakazu Kurita, Yoshihiro Kuwano, Taro Kono, Shien Seike, Shinsuke Takagi, Nobuyuki Takakura, Takao Tachibana, Shuichi Tanoue, Kumiko Chuman, Hiroki Nakaoka, Yasuhiro Nakamura, Fumio Nagai, Yasunari Niimi, Shunsuke Nosaka, Taiki Nozaki, Tadashi Nomura, Kazuki Hashimoto, Ayato Hayashi, Satoshi Hirakawa, Takeshi Hirabayashi, Taizo Furukawa, Hiroshi Furukawa, Yumiko Hori, Takanobu Maekawa, Kentaro Matsuoka, Hideki Mori, Eiichi Morii, Akira Morimoto, Yuta Moriwaki, Shunsuke Yuzuriha, Naoaki Rikihisa, Munezumi Fujita, Yasuyuki Yamahana, Kyoichi Deie, Asami Tozawa, Daisuke Hasegawa, Akira Higashiyama, Daisuke Maeda, Sachiko Asayama, Yuhki Arai, Yohei Iwata, Mayu Uka, Hidehito Usui, Mizuki Uchiyama, Saori Endo, Hideki Endo, Rintaro Ono, Naoya Oshima, Toshihiro Otsuka, Kuniaki Ohara, Shinji Kagami, Tomo Kakihara, Mototoshi Kato, Hiroki Kanamori, Masafumi Kamata, Ami Kawaguchi, Akiko Kishi, Hiroshi Kitagawa, Kiyokazu Kim, Tamotsu Kobayashi, Takeshi Saito, Yusuke Shikano, Shuichi Shimada, Keisuke Suzuki, Masataka Takahashi, Shohei Takami, Reiko Takeda, Aya Tanaka, Kaishu Tanaka, Satoru Tamura, Masashi Tamura, Kanako Danno, Kenji Tsuboi, Yuta Nakajima, Ryo Nakatani, Miho Noguchi, Akifumi Nozawa, Naoki Hashizume, Masashi Hayakawa, Daichi Hayashi, Takaya Fukumoto, Mamoru Honda, Norifumi Matsuda, Hayato Maruguchi, Naoki Murakami, Kiichiro Yaguchi, Shiho Yasue, Hiroki Yoshihara, Rika Yoshimatsu, Kiyohito Yamamoto, Shinji Wada   +116 more
wiley   +1 more source

Successful use of recombinant tissue plasminogen activator (r-TPA) for management of chylothorax associated with central venous thrombosis after neonatal cardiac surgery

The Egyptian Heart Journal, 2015
Postoperative chylothorax is a frequently encountered pathology occurring in up to 5% of patients undergoing surgery for repair of congenital heart disease.
Sameh R Ismail, Mahmoud Elbarbary, Mohamed S Kabbani   +2 more
doaj   +1 more source

Clinical Application of Progressive Suspension in Thoracoscopic Right Upper Lobectomy

ANZ Journal of Surgery, Volume 96, Issue 5, Page 1164-1170, May 2026.
ABSTRACT Objective To compare the clinical efficacy of the progressive suspension method and conventional thoracoscopic pulmonary resection in right upper lobectomy. Methods A prospective cohort study was conducted involving 60 patients admitted to the Department of Thoracic Surgery at Cangzhou Central Hospital from January 2024 to March 2025. Patients
Liankai Yang, Hao Hang, Bo Yang, Xiang Song, Fanyi Kong, Xiaoyun Bai, Hao Lu, Hongbo Guo   +7 more
wiley   +1 more source

Continuous Intraoperative Recurrent Laryngeal Nerve Monitoring in Transcervical Inflatable Mediastinoscopic Esophagectomy

Thoracic Cancer, Volume 17, Issue 8, April 2026.
Continuous intraoperative nerve monitoring (IONM) in transcervical inflatable mediastinoscopic esophagectomy may help identify and protect RLN. ABSTRACT Transcervical inflatable mediastinoscopic esophagectomy (TIME), with fewer incisions and without going through the thoracic cavity, may achieve the same results and lymph node dissection compared with ...
Luo Zhao, Zhijun Han, Yisheng Zhang, Zijia Liu, Jia He, Li Li   +5 more
wiley   +1 more source

Congenital chylothorax [PDF]

, 2020
Department of Surgery no. 1 “Nicolae Anestidi”, Nicolae Testemitanu State University of Medicine and Pharmacy, Institute of Emergency Medicine, Chisinau, Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de ...
Shor, Elina, Sirhan, Mohammad Shihadi
core  

Nivolumab-induced chylothorax in a patient with advanced gastric adenocarcinoma

European Journal of Case Reports in Internal Medicine
Chylothorax refers to the presence of chyle in the pleural space leading to respiratory compromise. Chylothorax secondary to gastric adenocarcinoma or immune checkpoint inhibitors, such as nivolumab, is exceedingly rare and has been documented only in ...
Youssef Hayssam Sultan, Radwan Zeidan, Mohammed Abdallah, Staphanie Joseph Mitri, Francois Georges Kamar   +4 more
doaj   +1 more source